Use of Moraxella catarrhalis lipooligosaccharide mutants to identify specific oligosaccharide epitopes recognized by human serum antibodies.
Moraxella catarrhalis is a causative agent of otitis media in children and lower respiratory tract infections in adults suffering from chronic obstructive pulmonary disease (COPD). This strict human pathogen continues to be a significant cause of disease in this broad spectrum of patients because there is no available vaccine. Although numerous putative vaccine antigens have been described, little is known about the human immune response to M. catarrhalis infection in vivo. Human serum antibodies are directed at a number of surface proteins, and lipooligosaccharides (LOS) and detoxified LOS may be an effective immunogen in mice. In this study, we used a specific LOS-based enzyme-linked immunosorbent assay (ELISA), containing the three major M. catarrhalis serotypes together with a complete series of truncated LOS mutants, to detect the development of new antibodies to specific regions of the oligosaccharide molecule. We compared serum samples from COPD patients who had recently cleared an M. catarrhalis infection to serum samples collected prior to their infection. Variability in the antibody response to LOS was observed, as some patients developed serotype-specific antibodies, others developed antibodies to the LOS of each serotype, others developed broadly cross-reactive antibodies, and some did not develop new antibodies. These newly developed human antibodies are directed at both side chains and core structures in the LOS molecule. This LOS-based ELISA can be used to dissect the human antibody response to both internal and external carbohydrate epitopes, thus providing a better understanding of the humoral immune response to M. catarrhalis LOS epitopes developed during natural infection.
Schwingel
Johanna M
JM
Department of Microbiology and Immunology, University at Buffalo, Buffalo, NY 14214, USA.
Edwards
Katie J
KJ
Cox
Andrew D
AD
Masoud
Hussein
H
Richards
James C
JC
St Michael
Frank
F
Tekwe
Carmen D
CD
Sethi
Sanjay
S
Murphy
Timothy F
TF
Campagnari
Anthony A
AA
D000328:Adult; D000907:Antibodies, Bacterial / Q000097:blood*; D002240:Carbohydrate Sequence; D002648:Child; D003429:Cross Reactions; D004269:DNA, Bacterial / Q000235:genetics; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D000939:Epitopes / Q000235:genetics / Q000276:immunology*; D006801:Humans; D008070:Lipopolysaccharides / Q000235:genetics / Q000276:immunology*; D008969:Molecular Sequence Data; D001936:Moraxella catarrhalis / Q000235:genetics / Q000276:immunology*; D009154:Mutation; D029424:Pulmonary Disease, Chronic Obstructive / Q000276:immunology; D017422:Sequence Analysis, DNA; D044967:Serum / Q000276:immunology*
D000907:Antibodies, Bacterial; D004269:DNA, Bacterial; D000939:Epitopes; D008070:Lipopolysaccharides; C023023:lipid-linked oligosaccharides